Related Experiment Video
Updated: Jul 8, 2025

08:28
Morphometric Protocol for the Objective Assessment of Blastocyst Behavior During Vitrification and Warming Steps
Published on: February 28, 2019
8.8K
Deep Learning-Based Quantitative Blastocyst Assessment
Summary
This study introduces a novel deep learning regression network with soft attention for precise, quantitative blastocyst quality assessment in IVF. The method accurately evaluates embryo viability by focusing on the inner cell mass, outperforming traditional classification approaches.
Area of Science:
- Embryology
- Artificial Intelligence
- Medical Imaging
Background:
- Blastocyst morphology assessment is critical for in vitro fertilization (IVF) success.
- Current deep learning methods often provide qualitative, rather than quantitative, blastocyst evaluations.
- Ranking blastocyst quality using qualitative assessments presents significant challenges.
Purpose of the Study:
- To develop a quantitative method for evaluating blastocyst quality using deep learning.
- To improve the precision of blastocyst quality assessment for IVF procedures.
- To introduce a regression network with a soft attention mechanism for this purpose.
Main Methods:
- A regression neural network combined with a soft attention mechanism was proposed.
- The network generates a continuous score for precise blastocyst quality evaluation.
- An attention module identifies and localizes regions of interest (inner cell mass) in blastocyst images.
Main Results:
- The proposed regression network quantitatively evaluates blastocyst quality.
- The soft attention mechanism accurately localizes the inner cell mass (ICM).
- The method demonstrated superior performance compared to traditional classification-based networks.
Conclusions:
- The developed deep learning model provides a more reliable and accurate quantitative assessment of blastocyst quality.
- The visualized attention maps enhance the interpretability and trustworthiness of the network's predictions.
- This approach offers a significant advancement for selecting optimal blastocysts in IVF treatment.

